Scarica l'app Stockscreener
16.38
2.44%
0.39
Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 6.7%Here's What Happened - MarketBeat
Should investors be concerned about SNDX’s high price-to-sales ratio? - US Post News
Syndax Pharmaceuticals (SNDX) Projected to Post Earnings on Tuesday - MarketBeat
Here's Why We're Watching Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation - Yahoo Finance
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
When (SNDX) Moves Investors should Listen - Stock Traders Daily
Syndax Pharmaceuticals' SWOT analysis: stock poised for growth with FDA approvals - Investing.com
Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Insider Sells 4,618 Shares of Stock - MarketBeat
Insider Selling: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Sells 3,777 Shares of Stock - MarketBeat
Michael A. Metzger Sells 13,288 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock - MSN
Don't Ignore The Insider Selling In Syndax Pharmaceuticals - Simply Wall St
abrdn plc Takes Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax pharmaceuticals CFO sells $58,558 in stock - MSN
Syndax Pharmaceuticals CEO sells $206,017 in shares - MSN
Syndax pharmaceuticals CFO Keith Goldan sells $58,558 in stock By Investing.com - Investing.com Australia
Syndax pharmaceuticals CFO sells $58,558 in stock By Investing.com - Investing.com Nigeria
Syndax Pharmaceuticals CEO sells $206,017 in shares By Investing.com - Investing.com South Africa
Syndax Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView
Is Syndax Pharmaceuticals Inc (SNDX) positioned for future growth? - SETE News
2 ‘Strong Buy’ Growth Stocks Poised For 141% To 193% Gains, According To Wall Street - Barchart
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap UpShould You Buy? - MarketBeat
Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewswire Inc.
Learn to Evaluate (SNDX) using the Charts - Stock Traders Daily
Syndax Pharmaceuticals Inc [SNDX] stock for 25,037 USD was acquired by Goldan Keith A. - Knox Daily
Syndax Pharmaceuticals Inc (SNDX) deserves deeper analysis - US Post News
Kura Oncology falls despite trial success; rival Syndax gains - Seeking Alpha
Can Syndax Pharmaceuticals Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
Syndax Expands Team: Strategic Stock Options Grant Signals Major Growth Phase - StockTitan
Ready to Jump After Recent Trade: Syndax Pharmaceuticals Inc (SNDX) - SETE News
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance
Syndax Leadership Reveals Growth Strategy at Elite Healthcare Investment Forums - StockTitan
Syndax Announces Participation in February Investor Conferences - Yahoo Finance
(SNDX) Investment Analysis and Advice - Stock Traders Daily
Incyte and Syndax to scale Niktimvo production after FDA approval - BioProcess Insider
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):